Of interest, our results are in line with previous clinical findings displaying an increase in pro-inflammatory cytokine concentrations, including TNF and IL-1β, and markers of glial cell activation (i.e., increase in ganglionic GFAP levels) in colonic biopsies from PD patients [17]. This evidence concerns the gene IL1B and Parkinson disease.